Registered entities
Lipocine Inc.
Reg. No. 1535955United States
Innovation
59 patent families (36 granted) — focus: Human necessities, Operations & transport, Chemistry & metallurgy; filing pace accelerating. Cited 18,914 times.
| Year | Filings |
|---|---|
| 2015 | 9 |
| 2016 | 17 |
| 2017 | 13 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 14 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 16 |
| 2025 | 17 |
| 2026 | 7 |
Social engagement
Social engagement: 1.8K social following, 3 posts in the last 12 months — above the industry median.
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
11 Sep 2025 · Scientist · Salt Lake City
Based on job postings tracked across public sources.
Recent activity
8 Jun 2026
Event
Virtual KOL event focused on postpartum depression (PPD) and LPCN 1154 (BRLIZIOTM) as a differentiated treatment option for women with PPD
23 Apr 2026
Product launch
Llipocine website